LUNG CANCER NON SMALL CELL
Clinical trials for LUNG CANCER NON SMALL CELL explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER NON SMALL CELL trials appear
Sign up with your email to follow new studies for LUNG CANCER NON SMALL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for three tough cancers
Disease control CompletedThis study tested a combination of two drugs (IO102-IO103 and pembrolizumab) as the first treatment for people with advanced lung, head & neck, or bladder cancer that has spread. The goal was to see if the combo could shrink tumors and delay cancer growth. A total of 63 patients …
Matched conditions: LUNG CANCER NON SMALL CELL
Phase: PHASE2 • Sponsor: IO Biotech • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
New drug combo aims to keep advanced lung cancer in check
Disease control CompletedThis study tested whether adding the drug niraparib to the immunotherapy pembrolizumab helps keep advanced non-small cell lung cancer from growing after initial chemotherapy. About 666 adults with stage IIIB/IV lung cancer whose disease was stable or improved after first-line tre…
Matched conditions: LUNG CANCER NON SMALL CELL
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 22, 2026 13:54 UTC